NDLI: Pathophysiological activities of the kallikrein-kinin system with emphasis on the cardiovascular disorders

Content Provider	Springer Nature Link
Author	Sharma, Jagdish N. Zubaid, Mohammad Khan, B. Zailina S. J. Yusof, A. Pauzi M. Asmawi, M. Zaini
Copyright Year	2000
Abstract	Recent evidence suggests an important role for the kallikrein-kinin system in the pathophysiology of hyperalgesia, arthritis, inflammatory bowel disease, pancreatitis, asthma and endotoxemia. In fact, hyperactivity of kinins can be considered as pro-inflammatory because of their ability to cause all the cardinal signs of inflammation directly activating their B$_{1}$ and B$_{2}$ receptors. Kinins are also able to release other potent inflammatory mediators. In endotoxemia, excessive kinin release may account for inducing severe life threatening hypotension. Several specific kinin receptor antagonists are being developed with the major interest in treating these pathological conditions to block the activation of kinin receptors. Furthermore, kallikrein inhibitors may have a role in the treatment of arthritis and inflammatory gut diseases to block the excessive release of kallikrein. On the other side, all the components of the kallikrein-kinin system are located in the vascular smooth muscle as well as in the heart. From numerous observations obtained from clinical and experimental models of diabetes, hypertension, cardiac failure, ischemia, myocardial infarction and left ventricular hypertrophy, it can be assumed that the reduced activity of the local kallikrein-kinin system may be instrumental for the induction of cardiovascular related diseases. The ability of kallikrein gene delivery to produce a wide spectrum of beneficial effects makes it an excellent candidate in treating hypertension, cardiovascular and renal diseases. In addition, stable kinin agonists may also be available in the future as therapeutic agents for cardiovascular and renal disorders.
Starting Page	219
Ending Page	241
Page Count	23
File Format	PDF
ISSN	09254692
Journal	InflammoPharmacology
Volume Number	8
Issue Number	3
e-ISSN	15685608
Language	English
Publisher	Brill Academic Publishers
Publisher Date	2000-01-01
Publisher Place	Leiden
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Pharmacology/Toxicology Allergology Rheumatology
Content Type	Text
Resource Type	Article
Subject	Pharmacology Immunology Pharmacology (medical)

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Pro-inflammatory properties of the kallikrein-kinin system: Potential for new drug therapy

The kallikrein-kinin system: from mediator of inflammation to modulator of cardioprotection

The kinin system in hypertensive pathophysiology

Evaluation of inflammatory kinin-forming components in experimental epilepsy in rats

Modifications in tissue kallikrein activity with indomethacin and prednisolone treatment in arthritic rats

Kallikrein-mediated activation of PARs in inflammation and nociception

The use of NSAIDs in rheumatic disorders 2005: a global perspective

PAF-induced kinin B1 receptor in vivo up-regulation: involvement of distinct kinase pathways

Positioning dual inhibitors in the treatment of pain and inflammatory disorders

Pathophysiological activities of the kallikrein-kinin system with emphasis on the cardiovascular disorders

Similar Documents

Pro-inflammatory properties of the kallikrein-kinin system: Potential for new drug therapy

The kallikrein-kinin system: from mediator of inflammation to modulator of cardioprotection

The kinin system in hypertensive pathophysiology

Evaluation of inflammatory kinin-forming components in experimental epilepsy in rats

Modifications in tissue kallikrein activity with indomethacin and prednisolone treatment in arthritic rats

Kallikrein-mediated activation of PARs in inflammation and nociception

The use of NSAIDs in rheumatic disorders 2005: a global perspective

PAF-induced kinin B1 receptor in vivo up-regulation: involvement of distinct kinase pathways

Positioning dual inhibitors in the treatment of pain and inflammatory disorders

Pathophysiological activities of the kallikrein-kinin system with emphasis on the cardiovascular disorders